Advancing breast cancer heterogeneity analysis: Insights from genomics, transcriptomics and proteomics at bulk and single-cell levels

Z Zhu, L Jiang, X Ding - Cancers, 2023 - mdpi.com
Simple Summary This review discusses the heterogeneity of breast cancer and strategies to
understand it using multi-omics profiling methods at the traditional bulk and single-cell …

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

JI Herschkowitz, K Simin, VJ Weigman, I Mikaelian… - Genome biology, 2007 - Springer
Background Although numerous mouse models of breast carcinomas have been developed,
we do not know the extent to which any faithfully represent clinically significant human …

EGFR associated expression profiles vary with breast tumor subtype

KA Hoadley, VJ Weigman, C Fan, LR Sawyer, X He… - BMC genomics, 2007 - Springer
Background The epidermal growth factor receptor (EGFR/HER1) and its downstream
signaling events are important for regulating cell growth and behavior in many epithelial …

Overview of genetically engineered mouse models of distinct breast cancer subtypes

J Usary, DB Darr, AD Pfefferle… - Current protocols in …, 2016 - Wiley Online Library
Advances in the screening of new therapeutic options have significantly reduced the breast
cancer death rate over the last decade. Despite these advances, breast cancer remains the …

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors

Y Wu, K Cui, K Miyoshi, L Hennighausen, JE Green… - Cancer research, 2003 - AACR
Insulin-like growth factors (IGFs) play a crucial role in regulating cell proliferation and
differentiation. The aim of this study was to examine the potential relationship between …

Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models

PJ Roberts, JE Usary, DB Darr, PM Dillon… - Clinical cancer …, 2012 - AACR
Purpose: Anticancer drug development is inefficient, but genetically engineered murine
models (GEMM) and orthotopic, syngeneic transplants (OST) of cancer may offer …

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis

O Aprelikova, K Chen, LH El Touny… - Clinical …, 2016 - Springer
Background Oncogene overexpression in primary cells often triggers the induction of a
cellular safeguard response promoting senescence or apoptosis. Secondary cooperating …

Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models

MA Shibata, C Kavanaugh, E Shibata, H Abe… - …, 2003 - academic.oup.com
The effects of lovastatin, a potent inhibitor of HMG CoA reductase, on experimental
mammary and prostate oncogenesis, were studied in vitro and in vivo. Lovastatin inhibited …

2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3 (1)/SV40 T/t-antigen …

JE Green, MA Shibata, E Shibata, RC Moon, MR Anver… - Cancer research, 2001 - AACR
Female transgenic mice that express SV40 T/t antigens under the regulatory control of the
rat C3 (1) gene spontaneously develop multifocal mammary lesions that predictably evolve …

Ras Stimulation of E2F Activity and a Consequent E2F Regulation of Integrin α6β4 Promote the Invasion of Breast Carcinoma Cells

SO Yoon, S Shin, AM Mercurio - Cancer research, 2006 - AACR
Active Ras proteins contribute to breast carcinogenesis and progression. Here, we provide
evidence that active H-Ras regulates the expression and activity of the E2F family of …